Pharmacokinetics, biodistribution, and in vivo toxicity of 7-nitroindazole loaded in pegylated and non-pegylated nanoemulsions in rats

Sepsis is a life-threatening condition caused by a dysregulated host response to infection. The development of sepsis is associated with excessive nitric oxide (NO) production, which plays an important role in controlling vascular homeostasis. 7-nitroindazole (7-NI) is a selective inhibitor of neuro...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of pharmaceutical sciences Vol. 194; p. 106695
Main Authors:	França, Angela Patricia, Silva, Thais Alves, Schulz, Daniela, Gomes-Pereira, Leonardo, Cunha, Livia Melo Arruda, Gonçalves, Merita Pereira, Vieira, João Victor Soares, Sanches, Mariele Paludetto, Koehler, Natalia, Maluf, Sharbel, Poli, Anicleto, da Silva-Santos, José Eduardo, Assreuy, Jamil, Lemos-Senna, Elenara
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01-03-2024
Subjects:	7-nitroindazole in vivo toxicity nanoemulsions pharmacokinetics sepsis 7-nitroindazole nanoemulsions pharmacokinetics sepsis in vivo toxicity
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Sepsis is a life-threatening condition caused by a dysregulated host response to infection. The development of sepsis is associated with excessive nitric oxide (NO) production, which plays an important role in controlling vascular homeostasis. 7-nitroindazole (7-NI) is a selective inhibitor of neuronal nitric oxide synthase (NOS-1) with potential application for treating NO imbalance conditions. However, 7-NI exhibits a low aqueous solubility and a short plasma half-life. To circumvent these biopharmaceutical limitations, pegylated (NEPEG7NI) and non-pegylated nanoemulsions (NENPEG7NI) containing 7-NI were developed. This study evaluates the pharmacokinetic profiles and toxicological properties of 7-NI loaded into the nanoemulsions. After a single intravenous administration of the free drug and the nanoemulsions at a dose of 10 mg.kg−1 in Wistar rats, 7-NI was widely distributed in the organs. The pharmacokinetic parameters of Cmax, t1/2, and AUC0-t were significantly increased after administration of the NEPEG7NI, compared to both free 7-NI and NENPEG7NI (p < 0.05). No observable adverse effects were observed after administering the free 7-NI, NEPEG7NI, or NENPEG7NI in the animals after a single dose of up to 3.0 mg.kg−1. The results indicated that 7-NI-loaded nanoemulsions are safe, constituting a promising approach to treating sepsis. [Display omitted]
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0928-0987 1879-0720
DOI:	10.1016/j.ejps.2024.106695